ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

The association between atherosclerosis and nonalcoholic fatty liver disease

Lv, Qing; Han, Qianqian; Wen, Ziyun; Pan, Yunyun; Chen, Jisheng*广东药学院; 南方医科大学; 1
Medicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries2024-1-5DOI: 10.1097/MD.0000000000036815
19阅读
引用收藏
分享

摘要

Atherosclerosis (AS) is closely related to nonalcoholic fatty liver disease (NAFLD), which promotes and exacerbates the development of AS. However, it is uncertain how the precise underlying mechanism occurs. Here, we attempted to further explore the association underlying atherosclerosis and nonalcoholic fatty liver disease through integrated bioinformatics analysis. Microarray data for atherosclerosis and nonalcoholic fatty liver disease were retrieved from the Gene Expression Omnibus (GEO) database. Weighted gene co-expression network analysis (WGCNA) was used to identify the genes related to atherosclerosis and nonalcoholic fatty liver disease showing co-expression. Additionally, the common gene targets associated with atherosclerosis and nonalcoholic fatty liver disease were also analyzed and screened using data from 3 public databases [comparative toxicogenomics database (CTD), DISEASES, and GeneCards]. The Gene Ontology (GO) enrichment analysis and the Kyoto encyclopedia of genes and genomes (KEGG) enrichment analysis were performed using Metascape R, respectively. The protein-protein interaction networks (PPI) network was constructed using Cytoscape. According to the results of an analysis of common genes, matrix metalloproteinase 9 (MMP9) is co-expressed up-regulated in AS and NAFLD and is enriched in inflammatory and immune-related collaterals. Consequently, MMP9 may work together through immunity and inflammation to treat AS and NAFLD and may be a potential therapeutic target in the future. The findings of this study provide new insights into the shared association between AS and NAFLD. MMP9 is co-expressed up-regulated in AS and NAFLD, which be able to reveal the presence of co-expressed genes in atherosclerosis and NAFLD.

学科与关键词

关键词
atherosclerosisbioinformaticsimmuneinflammatorynonalcoholic fatty liver
相关
加载中…
  • Identification of shared genetic architecture between non-alcoholic fatty liver disease and type 2 diabetes: A genome-wide analysis
    Tan, Yajing; He, Qian; Chan, Kei Hang Katie*Frontiers in Endocrinology, 2023, 14: 1050049.被引 1
  • Exploration of Shared Gene Signatures and Molecular Mechanisms Between Periodontitis and Nonalcoholic Fatty Liver Disease
    Xu, Wanqiu; Zhang, Zhengwei; Yao, Lihong; Xue, Bing; Xi, Hualei; Wang, Xiumei*; Sun, Shibo*Frontiers in Genetics, 2022, 13: 939751.被引 9
  • Integrated Bioinformatic Analysis of the Shared Molecular Mechanisms Between Osteoporosis and Atherosclerosis
    Mo, Liang; Ma, Chao; Wang, Zhangzheng; Li, Jianxiong; He, Wei; Niu, Wei; Chen, Zhengqiu*; Zhou, Chi*; Liu, Yuhao*Frontiers in Endocrinology, 2022, 13: 950030.被引 14
查看全部 →

发表信息

论文状态
公开发表
期刊
Medicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries
发表日期
2024-01-05
卷期
第 103 卷, 第 1 期
页码
e36815
DOI
10.1097/MD.0000000000036815
语言
ENGLISH
成果收录
SCIE
资助标注
Chinese National Natural Science Foundation [82074139]

作者

  • L

    Lv, Qing (第一作者)

    1 · guangdong pharmaceut univ

  • H

    Han, Qianqian

    1 · guangdong pharmaceut univ

查看全部 5 位作者收起作者
  • W

    Wen, Ziyun

    1 · guangdong pharmaceut univ

  • P

    Pan, Yunyun

    southern med univ

  • C

    Chen, Jisheng (通讯)

    1 · guangdong pharmaceut univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417